Zsofia K. Stadler

26.6k total citations · 2 hit papers
191 papers, 6.5k citations indexed

About

Zsofia K. Stadler is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Zsofia K. Stadler has authored 191 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Oncology, 95 papers in Pathology and Forensic Medicine and 79 papers in Cancer Research. Recurrent topics in Zsofia K. Stadler's work include Genetic factors in colorectal cancer (94 papers), Cancer Genomics and Diagnostics (74 papers) and BRCA gene mutations in cancer (40 papers). Zsofia K. Stadler is often cited by papers focused on Genetic factors in colorectal cancer (94 papers), Cancer Genomics and Diagnostics (74 papers) and BRCA gene mutations in cancer (40 papers). Zsofia K. Stadler collaborates with scholars based in United States, Canada and Israel. Zsofia K. Stadler's co-authors include Jinru Shia, Neil H. Segal, Andrea Cercek, Luis A. Díaz, Robin B. Mendelsohn, Karuna Ganesh, Mark E. Robson, Kenneth Offit, Erin Salo‐Mullen and Eileen M. O’Reilly and has published in prestigious journals such as Nature Communications, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Zsofia K. Stadler

180 papers receiving 6.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunotherapy in colorectal cancer: rationale, challenges and potential

2019 1.3k citations Zsofia K. Stadler, Andrea Cercek et al. profile →
Genome doubling shapes the evolution and prognosis of advanced cancers

2018 343 citations Craig M. Bielski, Ahmet Zehir et al. Nature Genetics profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Zsofia K. Stadler	3.8k	2.4k	2.1k	1.7k	1.2k	191	6.5k
Christophe Rosty	4.4k 1.1×	1.6k 0.7×	2.3k 1.1×	2.7k 1.6×	1.4k 1.1×	134	7.2k
Jean F. Simpson	3.0k 0.8×	2.4k 1.0×	2.3k 1.1×	1.9k 1.1×	790 0.6×	111	6.5k
Charlotte K.Y. Ng	2.6k 0.7×	3.5k 1.5×	1.4k 0.7×	2.4k 1.4×	1.5k 1.2×	120	6.5k
Rohit Bhargava	2.8k 0.7×	2.4k 1.0×	1.1k 0.5×	1.6k 1.0×	1.2k 1.0×	171	5.5k
Futoshi Akiyama	2.5k 0.7×	2.7k 1.1×	2.1k 1.0×	1.7k 1.0×	635 0.5×	251	6.1k
Andrew H.S. Lee	4.0k 1.0×	3.5k 1.5×	2.3k 1.1×	1.4k 0.8×	1.1k 0.9×	88	7.1k
Serban Dan Costa	4.8k 1.3×	4.2k 1.8×	1.7k 0.8×	1.3k 0.8×	978 0.8×	103	7.6k
Aaron Pollett	3.9k 1.0×	1.7k 0.7×	1.3k 0.6×	2.6k 1.6×	633 0.5×	87	6.8k
Talia Golan	5.4k 1.4×	2.3k 1.0×	735 0.4×	2.0k 1.2×	1.7k 1.3×	170	7.2k
Manuel R. Teixeira	1.7k 0.4×	1.9k 0.8×	1.3k 0.6×	3.4k 2.0×	1.9k 1.5×	225	6.4k

Countries citing papers authored by Zsofia K. Stadler

Since Specialization

Citations

This map shows the geographic impact of Zsofia K. Stadler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zsofia K. Stadler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zsofia K. Stadler more than expected).

Fields of papers citing papers by Zsofia K. Stadler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zsofia K. Stadler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zsofia K. Stadler. The network helps show where Zsofia K. Stadler may publish in the future.

Co-authorship network of co-authors of Zsofia K. Stadler

This figure shows the co-authorship network connecting the top 25 collaborators of Zsofia K. Stadler. A scholar is included among the top collaborators of Zsofia K. Stadler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zsofia K. Stadler. Zsofia K. Stadler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Widmar, Maria, Iris H. Wei, Emmanouil P. Pappou, et al.. (2024). Clinical Calculator for Predicting Freedom From Recurrence After Resection of Stage I-III Colon Cancer in Patients With Microsatellite Instability. JCO Clinical Cancer Informatics. 8(8). e2300233–e2300233. 1 indexed citations

Ceyhan‐Birsoy, Ozge & Zsofia K. Stadler. (2024). Tumor-Only Sequencing: A Story Only Half Told. JCO Precision Oncology. 8(8). e2400226–e2400226. 1 indexed citations

Shia, Jinru, Francisco Sánchez-Vega, Jie‐Fu Chen, et al.. (2024). MSH6-proficient crypt foci in MSH6 constitutional mismatch repair deficiency: reversion of a frameshifted coding microsatellite to its wild-type sequence. Familial Cancer. 23(4). 569–577.

Tang, Laura H., Kanika Arora, Stephanie King, et al.. (2024). Differences in Ancestry and Presence of Gastric Precursor Lesions in Individuals With Young‐ and Average‐Onset Gastric Cancer. Cancer Medicine. 13(23). e70451–e70451. 1 indexed citations

Mandelker, Diana, Antonio Marra, Nikita Mehta, et al.. (2023). Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterations. npj Precision Oncology. 7(1). 34 indexed citations

Foote, Michael B., Henry Walch, Yelena Kemel, et al.. (2023). The Impact of Germline Alterations in Appendiceal Adenocarcinoma. Clinical Cancer Research. 29(14). 2631–2637. 2 indexed citations

Cercek, Andrea, Melissa Lumish, Jenna Sinopoli, et al.. (2023). PS4-2 PD-1 blockade as curative intent therapy in mismatch repair deficient locally advanced rectal cancer. Annals of Oncology. 34. S1381–S1381. 3 indexed citations

Liu, Ying L., Karen A. Cadoo, Anna Maio, et al.. (2022). Early age of onset and broad cancer spectrum persist in MSH6- and PMS2-associated Lynch syndrome. Genetics in Medicine. 24(6). 1187–1195. 10 indexed citations

Vanderbilt, Chad, Jin K. Kim, Chin‐Tung Chen, et al.. (2021). Tumor-Infiltrating Lymphocytes, Tumor Mutational Burden, and Genetic Alterations in Microsatellite Unstable, Microsatellite Stable, or Mutant POLE/POLD1 Colon Cancer. JCO Precision Oncology. 5(5). 817–826. 22 indexed citations

10.

Murciano‐Goroff, Yonina R., Alexander Drilon, & Zsofia K. Stadler. (2021). The NCI-MATCH: A National, Collaborative Precision Oncology Trial for Diverse Tumor Histologies. Cancer Cell. 39(1). 22–24. 22 indexed citations

11.

Seah, Davinia, José Pablo Leone, Thomas H. Openshaw, et al.. (2020). Perceptions of patients with early stage breast cancer toward research biopsies. Cancer. 127(8). 1208–1219. 3 indexed citations

12.

Saldia, Amethyst, Sara H. Olson, Xiaolin Liang, et al.. (2019). Outcome of Pancreatic Cancer Surveillance Among High-Risk Individuals Tested for Germline Mutations in BRCA1 and BRCA2. Cancer Prevention Research. 12(9). 599–608. 5 indexed citations

13.

Ravichandran, Vignesh, Yelena Kemel, Michael F. Walsh, et al.. (2019). Toward automation of germline variant curation in clinical cancer genetics. Genetics in Medicine. 21(9). 2116–2125. 21 indexed citations

14.

Bielski, Craig M., Ahmet Zehir, Alexander Penson, et al.. (2018). Genome doubling shapes the evolution and prognosis of advanced cancers. Nature Genetics. 50(8). 1189–1195. 343 indexed citations breakdown →

15.

Mondaca, Sebastián, Walid K. Chatila, ‬David D. B. Bates, et al.. (2018). FOLFCIS Treatment and Genomic Correlates of Response in Advanced Anal Squamous Cell Cancer. Clinical Colorectal Cancer. 18(1). e39–e52. 18 indexed citations

16.

Hellmann, Matthew D., Jedd D. Wolchok, Monika Vyas, et al.. (2018). Acquired resistance to immunotherapy in MMR-D pancreatic cancer. Journal for ImmunoTherapy of Cancer. 6(1). 127–127. 27 indexed citations

17.

Katona, Bryson W., Matthew B. Yurgelun, Judy E. Garber, et al.. (2018). A counseling framework for moderate-penetrance colorectal cancer susceptibility genes. Genetics in Medicine. 20(11). 1324–1327. 24 indexed citations

18.

Janjigian, Y. Y., Francisco Sánchez-Vega, Philip Jonsson, et al.. (2016). Clinical next generation sequencing (NGS) of esophagogastric (EG) adenocarcinomas identifies distinct molecular signatures of response to HER2 inhibition, first-line 5FU/platinum and PD1/CTLA4 blockade. Annals of Oncology. 27. vi208–vi208. 3 indexed citations

19.

Seah, Davinia, Julie Najita, Thomas H. Openshaw, et al.. (2013). Attitudes of patients with metastatic breast cancer toward research biopsies. Annals of Oncology. 24(7). 1853–1859. 24 indexed citations

20.

Collins, Laura C., M. Kandel, Zsofia K. Stadler, et al.. (2009). Basal Cytokeratin and Epidermal Growth Factor Receptor Expression Are Not Predictive of BRCA1 Mutation Status in Women With Triple-negative Breast Cancers. The American Journal of Surgical Pathology. 33(7). 1093–1097. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact